retatrutide trial results news Eli Lilly says next-generation weight loss drug clears crucial obesity Eli Lilly retatrutide Phase 3

To date, no studies have specifically investigated GLP-1RAs in early PsA

That said, weight loss in people with diabetes is still clinically meaningful and often leads to: Improved glucose control Reduced medication requirements Lower cardiovascular risk Better energy levels and mobility Important considerations GLP-1 medications are not cosmetic weight-loss drugs

Gen Physiol Biophys

Biochem Soc Trans 44(2):582588 Furman BL (2012) The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent

Increased intakes of fibre and monounsaturated fats (found in olive oil and avocadoes) as well as the time of day when foods are eaten, the order that foods are eaten in, the speed of eating and even chewing can naturally stimulate increased production of the same hormone responsible for the effects of semaglutide drugs